- This event has passed.
Explore the COSENTYX® (secukinumab) Evidence for Non-Radiographic Axial Spondyloarthritis (nr-axSpA)
November 6, 2021 from 12:30 pm - 1:30 pm EDT
Sergio Schwartzman, MD
Franchellie M. Cadwell Chair Emeritus, Hospital for Special Surgery
Clinical Associate Professor Medicine, Weill Cornell Medical Center
Associate Attending Physician, New York Presbyterian Hospital
Associate Attending Physician, Hospital for Special Surgery
New York, New York
This program reviews the burden of disease experienced by patients across the spectrum of axial spondyloarthritis (axSpA), which includes non-radiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS), as well as clinical data for COSENTYX that support its use as a first-line biologic treatment for both patient populations, focusing on the latest data from the PREVENT study in nr-axSpA and also including 5-year results from the MEASURE 2 trial in AS. The program additionally explores axial symptoms in patients with psoriatic arthritis (PsA) and presents a look at the latest data from MAXIMISE, the first and only dedicated biologic study of axial manifestations in patients with PsA.
Additional Speaker Notes:
Dr Sergio Schwartzman has provided clinical care in rheumatology for over three decades. He is an Associate Attending Physician at Weill Cornell Medical College of Cornell University, the New York-Presbyterian Hospital, and the Hospital for Special Surgery in New York City. For nearly 34 years, Dr Schwartzman has had a full-time affiliation with the Hospital for Special Surgery, where he is the Franchellie M. Cadwell chair emeritus. He is also in private practice in the Upper East Side of Manhattan in New York City. Dr Schwartzman has authored, coauthored, and edited over 140 papers, abstracts, books, and book chapters on topics including psoriatic arthritis and axial spondyloarthritis, autoimmune ophthalmic diseases and Inflammatory Bowel Disease associated arthritis as well as other rheumatological and autoimmune conditions. He is a member of the American College of Rheumatology, the Spondyloarthritis Research and Treatment Network, and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis, and he has been on the medical board of the National Psoriasis Foundation.
This is not an official function/event of the American College of Rheumatology.